Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

iPALT

From Wikipedia, the free encyclopedia
(Redirected fromIsopropylallyltryptamine)

Pharmaceutical compound
IPALT
Clinical data
Other namesALiPT; ASR-3003; ASR3003;N-Isopropyl-N-allyltryptamine;N-Allyl-N-isopropyltryptamine
Drug classSerotonin receptor modulator;Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • N-[2-(1H-indol-3-yl)ethyl]-N-prop-2-enylpropan-2-amine
PubChemCID
Chemical and physical data
FormulaC16H22N2
Molar mass242.366 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC1=CNC2=CC=CC=C21)CC=C
  • InChI=1S/C16H22N2/c1-4-10-18(13(2)3)11-9-14-12-17-16-8-6-5-7-15(14)16/h4-8,12-13,17H,1,9-11H2,2-3H3
  • Key:DYIILRIYTXJTNJ-UHFFFAOYSA-N

iPALT, orALiPT, also known asN-isopropyl-N-allyltryptamine or by its developmental code nameASR-3003, is aserotonin receptor modulator of thetryptamine family.[1] It is an asymmetricalanalogue ofdiisopropyltryptamine (DiPT) anddiallyltryptamine (DALT).[1] The drug is anon-selectiveserotonin receptor agonist, including of theserotonin5-HT1B,5-HT2A,5-HT2B, and5-HT6 receptors, but not of the serotonin5-HT1A receptor.[1] It is also aserotonin reuptake inhibitor, but does not inhibitdopamine ornorepinephrinereuptake.[1] The drug shows rather lowpotency for many of these actions, with for example 47-fold lower potency as a serotonin 5-HT2A receptor agonist than the knownpsychedelic drug5-MeO-iPALT (ASR-3001).[1] Thechemical synthesis of iPALT has been described.[1]Derivatives of iPALT include 5-MeO-iPALT (ASR-3001),4-HO-iPALT, and2-Me-iPALT (ASR-3002).[1] 5-MeO-iPALT is known to be apsychedelic drug in humans and is under development for potential medical use.[2][3][4][5] iPALT waspatented by theAlexander Shulgin Research Institute (ASRI) in 2024.[1]

See also

[edit]

References

[edit]
  1. ^abcdefghUS 20240277665A1, Daley PF, Cozzi NV, Callaway WB, "Asymmetric allyl tryptamines", issued 4 March 2024, assigned to Alexander Shulgin Research Institute Inc. 
  2. ^"Delving into the Latest Updates on Tryptamine(ASRI) with Synapse".Synapse. 16 April 2025. Retrieved19 April 2025.
  3. ^Goldstein L (10 July 2023)."Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research".Benzinga. Retrieved19 April 2025.
  4. ^Busby M (2 November 2023)."The Heirs to a Vault of Novel Psychedelics Take a Trip Into the Unknown".DoubleBlind Mag. Retrieved19 April 2025.
  5. ^Busby M (30 March 2025)."What Happens When You Inherit 500 Psychedelic Compounds?".DoubleBlind Mag. Retrieved19 April 2025.

External links

[edit]
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=IPALT&oldid=1323859390"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp